Navigation Links
IPC The Hospitalist Company Announces Board of Director Member Changes
Date:3/20/2008

NORTH HOLLYWOOD, Calif., March 20 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading provider of hospitalist services, announced today the election of Woodrin Grossman to its board of directors. Mr. Grossman will serve on the audit and nominating and governance committees.

In June 2005, Mr. Grossman retired as partner and healthcare practice leader of PricewaterhouseCoopers after 37 years of service with the firm. With PricewaterhouseCoopers, Mr. Grossman served as the audit partner for audits of Fortune 500 and other companies. Mr. Grossman served as Senior Vice President-Strategy and Development of Odyssey HealthCare Inc. from January 2006 to December 2007 and as a director from July 2005 to January 2006. Mr. Grossman received a B.S. from Moravian College and an MBA from the Wharton School at the University of Pennsylvania. He currently serves on the board of Kinetic Concepts Inc. and Encompass Home Health.

Adam D. Singer, M.D., Chief Executive Officer, noted, "I am pleased to welcome Woody Grossman to our board. Woody is a seasoned executive in the healthcare industry who brings a breadth of industry knowledge and auditing expertise that will be extremely valuable to us as a newly public company. We look forward to working with Woody as we focus on enhancing our performance and achieving our goal of continuing to be a leader in the hospitalist space."

IPC also announced that long standing board member, Barry Smith has informed the board that he will tender his resignation effective with the next board meeting as he has been asked by the leadership of the LDS Church to serve full-time as a mission president requiring him to leave all for-profit and non-profit boards.

Dr. Singer commented, "Barry has been a valuable member of the IPC team for many years and we will certainly miss working with him personally and the health care business expertise he brought to our board, but we wish him well in his new role."

About IPC The Hospitalist Company

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at http://www.hospitalist.com.

Contacts:

Devra Shapiro Stephanie Carrington/Jared Hoffman

IPC The Hospitalist Company, Inc. The Ruth Group

(818) 766-3502 646-536-7017/7013

scarrington@theruthgroup.com

jhoffman@theruthgroup.com


'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results
2. IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters Over-Allotment Option
3. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
4. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
5. Hospitalist Physicians Help Shorten Patient Stays
6. Benefits of hospitalist care confirmed in new study
7. Abaxis, Inc. to Present at the Sidoti & Company Twelfth Annual New York Emerging Growth Institutional Investor Forum
8. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
9. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
10. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
11. Statement from Eli Lilly and Company: Response to Todays New York Times Article, Lilly E-Mail Discussed Off-Label Drug Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... ... March 01, 2017 , ... ... permanently embedded anti-odor solution to cotton knit and woven fabrics. , Retail ... maintaining the luxurious look and feel of cotton. Cotton Incorporated has developed ...
(Date:3/1/2017)... HILLS, CA (PRWEB) , ... March 01, 2017 , ... ... cryoablation for the treatment of early stage breast cancer and where it fits in ... Genes & The Choices We Make .” The event brings together leading cancer and ...
(Date:3/1/2017)... ... March 01, 2017 , ... Expert on international living and leading a ... & Go. , Time & Go app is the ultimate strategic compass that helps ... time management methods enable people to work smarter, not harder, that's why Time & ...
(Date:3/1/2017)... York, NY & Greenwich, CT (PRWEB) , ... March 01, 2017 ... ... many runners, especially in the winter months when people don’t want to stop training ... the knees – and setting the treadmill to a small incline can help protect ...
(Date:3/1/2017)... ... March 01, 2017 , ... “McFarnia”: a suspenseful tale of ... truth about his life and mysterious disappearance. “McFarnia” is the creation of published author ... North Carolina. He currently serves as a Chaplain with Transport for Christ at a ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Calif. , March 1, 2017   Sun Chlorella ... about all things chlorella, is pleased to announce Non-GMO Project ... premium chlorella powder. Just in time for the ... in Anaheim, CA , Sun Chlorella Corp. ... all chlorella products, including: Sun Chlorella ...
(Date:3/1/2017)... 2017  Integrated Modular Design (IMD), a ... implementation of pre-fabricated healthcare products like bathroom ... seeks to lead the construction industry toward ... Fueled by their leading-edge pre-fabrication solutions, ... construction timelines and project risk, and increasing ...
(Date:3/1/2017)... 1, 2017  Global biotherapeutics leader CSL Behring ... ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, known as ... reatment with H izentra ® ).  The Phase ... safety and tolerability of two different doses of CSL ... Subcutaneous [Human]), compared with placebo, in the maintenance treatment ...
Breaking Medicine Technology: